EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Mortality Assessment in Patients with Cardiovascular Disease and COVID-19: A Systematic Review and Meta-Analysis

Małgorzata Jarończyk iD, Jarosław Walory iD

International Journal of Molecular Sciences · 14.05.2026 · 27 (10) · 4375

DOI: 10.3390/ijms27104375 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.05.2026. Verfasst von Małgorzata Jarończyk und 1 weiteren Autor:innen. Beteiligte Einrichtung: Paediatric Regional Centre for Digital Medicine, The Children's Memorial Health Institute, 04-730 Warsaw, Poland. Hauptthemen laut MEDLINE: Cardiovascular Diseases, COVID-19. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The COVID-19 pandemic has had a profound impact on global health, especially among patients with cardiovascular disease (CVD) and the existence of additional conditions such as diabetes (DM), hypertension (HT), and chronic kidney disease (CKD) can have a significant impact on survival rates. The aim of this study was to determine the mortality rate in patients with CVD and the impact of other comorbidities on the death of patients with COVID-19. This systematic review was conducted using PubMed, EMBASE, and Google Scholar databases from August 2020 to June 2025. Inclusion criteria were patients with cardiovascular disease and associated comorbidities during the COVID-19 pandemic. Article selection was limited to articles published in English and Polish. Statistical analysis using a random-effects model was performed using STATA software. Heterogeneity between studies was examined, and a funnel plot for publication bias was generated. The higher mortality rates (OR = 3.00, 95% CI: 2.06–4.38) for patients with cardiovascular disease were observed. In the group of patients with comorbidities such as hypertension and diabetes mellitus the risk of death was also determined and for HT was OR = 1.94, 95% CI, 1.50–2.52 and for DM OR = 2.17, 95% CI: 1.64–2.86. The mortality in the chronic kidney disease group was higher than for HT and DM (OR = 3.91, 95% CI: 2.50–6.10). The risk of death is three times higher for patients with COVID-19 and CVD. High mortality risk is also linked to diabetes and hypertension but for chronic kidney disease patients increased up to four times.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesCOVID-19HumansComorbidityHypertensionDiabetes MellitusSARS-CoV-2Renal Insufficiency, Chronic

Stichwörter der Autor:innen

COVID-19cardiovascular diseasechronic kidney diseasediabetes mellitushypertensionmortality

Autor:innen und Institutionen

  • Paediatric Regional Centre for Digital Medicine, The Children's Memorial Health Institute, 04-730 Warsaw, Poland.
  • Department of Medical Biology, Digital Medicine Center-Biobank, Cardinal Stefan Wyszynski National Institute of Cardiology, 04-628 Warsaw, Poland.

ORCID-Profile: Małgorzata Jarończyk, Jarosław Walory

Zitieren

APA

Jarończyk, M., & Walory, J. (2026). Mortality Assessment in Patients with Cardiovascular Disease and COVID-19: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences, 27(10), 4375. https://doi.org/10.3390/ijms27104375

Vancouver

Jarończyk M, Walory J. Mortality Assessment in Patients with Cardiovascular Disease and COVID-19: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 2026;27(10):4375. doi:10.3390/ijms27104375

BibTeX
@article{Jaroczyk2026,
  author = {Jarończyk, Małgorzata and Walory, Jarosław},
  title = {Mortality Assessment in Patients with Cardiovascular Disease and COVID-19: A Systematic Review and Meta-Analysis},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {10},
  pages = {4375},
  doi = {10.3390/ijms27104375}
}
Kostenlos starten →